HLS.AXライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (2 5月 2024 @ 09:07):

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others...

Stats
本日の出来高	52 109.00
平均出来高	2.80M
時価総額	835.02M
EPS	$0 ( 2024-02-26 )
Last Dividend	$0.0600 ( 2022-09-07 )
Next Dividend	$0 ( N/A )
P/E	-0.700
ATR14	$0.00500 (0.43%)

ボリューム相関

長: 0.08 (neutral)

短: -0.37 (neutral)

Signal:(53.661) Neutral

Healius Ltd 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Healius Ltd 相関 - 通貨/商品

-0.12
( neutral )

-0.74
( moderate negative )

0.00
( neutral )

0.11
( neutral )

Healius Ltd 財務諸表

Annual	2023
収益:	$1.71B
総利益:	$341.70M (20.02 %)
EPS:	$-0.630

FY	2023
収益:	$1.71B
総利益:	$341.70M (20.02 %)
EPS:	$-0.630

FY	2022
収益:	$2.34B
総利益:	$2.02B (86.44 %)
EPS:	$0.530

FY	2021
収益:	$1.90B
総利益:	$1.63B (85.76 %)
EPS:	$0.0702

Financial Reports:

No articles found.

Healius Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.0600 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Healius Ltd Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 1.719 - low (50.00%) | Divividend Growth Potential Score: 1.361 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0237	1999-04-12
Last Dividend	$0.0600	2022-09-07
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	47	--
Total Paid Out	$3.43	--
Avg. Dividend % Per Year	0.00%	--
Score	1.43	--
Div. Sustainability Score	1.719
Div.Growth Potential Score	1.361
Div. Directional Score	1.540	--

Next Divdend (Est)
(2024-06-24)

$0 Estimate 0.00 %

Dividend Stability

0.10 Very Bad

Dividend Score

1.43

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
REH.AX	Ex Dividend Knight	2023-10-10	Semi-Annually	0.00%
BOQ.AX	Ex Dividend Junior	2023-05-10	Annually	0.00%
KPG.AX	Ex Dividend Knight	2023-07-20	Monthly	0.00%
SPK.AX	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
COF.AX	Ex Dividend Junior	2023-09-28	Quarterly	0.00%
MVF.AX	Ex Dividend Junior	2023-09-07	Annually	0.00%
WAM.AX	Ex Dividend Knight	2023-10-17	Semi-Annually	0.00%
EGG.AX	Ex Dividend Knight	2023-09-19	Semi-Annually	0.00%
PBH.AX	No Dividend Player	2023-09-06	Insufficient data to determine frequency	0.00%
ALL.AX	Ex Dividend Knight	2023-05-25	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.580	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.325	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.768	1.500	-9.64	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.527	0.800	-2.36	-1.890	[1 - 3]
quickRatioTTM	0.471	0.800	-1.934	-1.547	[0.8 - 2.5]
cashRatioTTM	0.144	1.500	-0.313	-0.470	[0.2 - 2]
debtRatioTTM	0.224	-1.500	6.27	-9.40	[0 - 0.6]
interestCoverageTTM	1.020	1.000	-0.733	-0.733	[3 - 30]
operatingCashFlowPerShareTTM	0.428	2.00	9.86	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.314	2.00	9.84	10.00	[0 - 20]
debtEquityRatioTTM	0.644	-1.500	7.43	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.185	1.000	-0.246	-0.246	[0.2 - 0.8]
operatingProfitMarginTTM	0.0421	1.000	-1.158	-1.158	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.376	1.000	9.02	9.02	[0.2 - 2]
assetTurnoverTTM	0.561	0.800	9.59	7.68	[0.5 - 2]
Total Score				1.719

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.711	1.000	-0.173	0	[1 - 100]
returnOnEquityTTM	-0.768	2.50	-6.20	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.314	2.00	9.90	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.428	2.00	9.86	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00328	1.500	-3.31	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.150	1.000	8.75	0	[0.1 - 0.5]
Total Score				1.361

Healius Ltd

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.